A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

A new solution may be on the horizon for the 30 million people in the U.S. who suffer from sleep apnea. In a Finland study, a new breathing device showed promising results in reducing symptoms of the ...

A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...

A repurposed epilepsy drug called sultiame cut breathing interruptions during sleep by up to 50% in adults with moderate-to-severe obstructive sleep apnea, according to results from a major European ...

A wearable pulse oximeter and connected software platform show promise for monitoring obstructive sleep apnea (OSA) and other sleep-related breathing diseases, according to research presented at the ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

Hospital patients sleeping near windows sleep better than those in other parts of a ward, according to a new study from the University of Surrey and the University of Padova. Fluctuating noise levels ...